Collaboration with MD Anderson

AI Medical and The University of Texas MD Anderson Cancer Center announce collaboration to accelerate efforts to advance the neuroimaging industry

· Collaborations

The collaboration will focus on advancing neuroimaging strategies for AI Medical's potent and selective software Jazz, explicitly focusing on brain metastases. 

The University of Texas MD Anderson Cancer Center, the top-ranked cancer hospital in the United States, is collaborating with AI-Medical to increase the quality and effectiveness of neuroradiology reporting for brain metastasis using the AI-based neuroimaging software Jazz. 

Between 20 and 40 percent of solid tumors develop brain metastasis[1], which has a median survival time between 4 and 16 months[2] and usually derives from lung, breast cancer, or melanoma[3]. 

The first step of treating brain metastasis is detecting them – the earlier, the better. The software Jazz, developed by AI Medical, helps neuroradiologists to detect and annotates brain metastasis on brain scans efficiently and with precision, reducing the amount of missed lesions to the absolute minimum. 

Timely identification and findings of metastases, as well as fast and high-quality reports are vital for all patients, regardless of the radiologists' workload or other human factors that can result in low-quality reports. MD Anderson Cancer Center and AI Medical will work side by side to continue to advance the functionality of Jazz so that the MD Anderson Cancer Center, the top-ranked cancer hospital in the US, can soon implement it within their premises.

 


 

[1] Herbert B. Newton, Chapter 3 - Overview of Pathology and Treatment of Metastatic Brain Tumors, Editor(s): Herbert B. Newton, Handbook of Neuro-Oncology Neuroimaging (Second Edition), Academic Press, 2016, Pages 23-33, ISBN 9780128009451, https://doi.org/10.1016/B978-0-12-800945-1.00003-3.

[2] Amin S, Baine MJ, Meza JL, Lin C. Association of Immunotherapy with Survival Among Patients with Brain Metastases Whose Cancer Was Managed with Definitive Surgery of the Primary Tumor. JAMA Netw Open. 2020;3(9): e2015444. doi:10.1001/jamanetworkopen.2020.15444

[3] Claudia C. Faria, Rita Cascão, Carlos Custódia, Eunice Paisana, Tânia Carvalho, Pedro Pereira, Rafael Roque, José Pimentel, José Miguéns, Isidro Cortes-Ciriano, João T. Barata, Patient-derived models of brain metastases recapitulate human disseminated disease, Cell Reports Medicine, Volume 3, Issue 5, 2022, 100623, ISSN 2666-3791, https://doi.org/10.1016/j.xcrm.2022.100623. 

 

 

 

 

 

 

 

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OK